In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.

In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.

Item
http://www.wikidata.org/entity/Q34238652
Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewSource and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer.Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Dynamic Aspects of Macrophage Polarization during Atherosclerosis Progression and Regression.High-density lipoprotein mimetics: promises and challenges.Investigational therapies for hypercholesterolemia.The potential of apolipoprotein mimetic peptides in the treatment of atherosclerosisSelf-Assembling Cyclic d,l-α-Peptides as Modulators of Plasma HDL Function. A Supramolecular Approach toward Antiatherosclerotic Agents.Mimetic peptides of human apoA-I helix 10 get together to lower lipids and ameliorate atherosclerosis: is the action in the gut?Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial.Recent Advances in Managing Atherosclerosis via Nanomedicine.Peptide Mimetics: Fast-Forward Look.Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer.
P2860

In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I.

Item
http://www.wikidata.org/entity/Q34238652
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@ast
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@nl
type
label
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@ast
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@nl
prefLabel
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@ast
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
In vivo efficacy of HDL-like n ...... imetics of apolipoprotein A-I.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932